PB2359: HEALTHCARE RESOURCE UTILIZATION OF ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A REAL WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA

por Zagadailov, E., Garcia-Horton, V., Higa, S., Shi, L.
Publicado 2022

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

por Parker, K., Zagadailov, E. A., Bruno, A. S., Wiland, A. M.
Publicado 2013

P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL

por Kuo, K. H., Grace, R. F., van Beers, E. J., Barcellini, W., Glenthøj, A., Holzhauer, S., Patel, P., Beynon, V., Li, J., Zagadailov, E., Al-Samkari, H.
Publicado 2022